Alternatively, one Fab region of the BsAb will bind to a tumor receptor, while the other region will bind to the CD3 domain of T cells, resulting in localization, polyclonal proliferation, and specific lysis of the tumor via CD8+ T cells (Figure 3A) [35]. The gene discussed is CD8A; the disease is neoplasm.